Eric Widera, MD

Eric Widera, MD

@ewidera.bsky.social

Professor of #Medicine @UCSF focused on #Geriatrics, #Hospice, #Palliative care, and #meded. Co-creator of https://eprognosis.ucsf.edu. Podcasts at http://geripal.org 🇺🇦 Publications: https://profiles.ucsf.edu/eric.widera

2.6K followers1.4K following285 posts

In geriatrics, weight loss is rarely simple. In older bodies, GLP1s carry increased risks, including accelerated muscle loss, functional decline, and possibly decreased bone density. So are we just trading weight loss for frailty? geripal.org/weight-loss-...

geripal.orgWeight loss, GLP1s and Sarcopenia: A Podcast with John Batsis, Shen Dewar, Aruna JosyulaToday we discuss the growing trend of palliative care doctors seeing more and more patients, sometimes with conditions not ordinarily considered.

Eric Widera, MD reposted

Thank you @alexsmithmd.bsky.social and @ewidera.bsky.social for highlighting our research on @geripal.bsky.social

GeriPal Podcast@geripal.bsky.social

When should doctors say "no" to treatments that won't help? We talk to Jason Batten, Liz Dzeng & Teva Brender about the real-world, unwritten "workarounds" clinicians use when standard ICU guidelines fail. #medsky   👉 bit.ly/GeriPalEp408 😀 Hosts: @alexsmithmd.bsky.social | @ewidera.bsky.social

Eric Widera, MD reposted

1- A tale of a "me too" drug ... FDA approved benzgalantamine for Alzheimer's disease in 2024 on an alternate pathway for modified drugs. Benzgalantamine is a modified version of galantamine that bypasses metabolism in the gut and so might be better tolerated. ebm.bmj.com/content/earl...

Eric Widera, MD reposted

Eric Widera, MD reposted

How Pharma exploites a regulatory loophole allowing approval of high-priced, minimally modified drugs based on limited data. This example is on an Alzheimer’s drug called Zunveyl which is basically galantamine without safety data in the population that it’s indicated in. ebm.bmj.com/content/earl...

ebm.bmj.comFDA approval of benzgalantamine exposes flaws in the 505(b)(2) pathway for innovations on existing drugsWhen the US Food and Drug Administration (FDA) approved benzgalantamine (Zunveyl) in July 2024 for Alzheimer’s disease, it was hailed by its manufacturer as a ‘major breakthrough’.1 In reality, benzga...

Eric Widera, MD reposted

Eric Widera, MD reposted

“…the growing enthusiasm for biomarkers risks obscuring a fundamental truth: biomarkers only reflect disease pathology. They cannot assess cognition or illuminate the functional changes that transform memory concerns into meaningful impairment.” #alz jamanetwork.com/journals/jam...

jamanetwork.comImportance of Function for Alzheimer Diagnosis and ManagementThis Viewpoint offers a reminder, amid new laboratory testing for Alzheimer disease, of the primary care practitioner’s important role in functional assessment of activities of daily living.

Eric Widera, MD reposted

The killing of Alex Pretti is a heartbreaking tragedy. It should also be a wake-up call to every American, regardless of party, that many of our core values as a nation are increasingly under assault.

Eric Widera, MD reposted

Alex Pretti was a colleague at the VA. We hired him to recruit for our trial. He became an ICU nurse- I lover working with him. He was a good kind person who lived to help and these fuckers executed him. White. Hot. Rage.

Eric Widera, MD reposted